# Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)

> **NCT03694470** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 10000 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03694470
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-15
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 10000 (ACTUAL)
- **Last updated:** 2019-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03694470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03694470, "Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03694470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*